Does acoramidis replace tafamidis for someone who's been on it for 18 months?
No, acoramidis doesn't replace tafamidis. Both medications are FDA-approved transthyretin stabilizers for treating ATTR-CM, and they work similarly by preventing the protein from breaking apart and forming amyloid deposits.
Acoramidis is a newer Show Full Answer
Does acoramidis replace tafamidis for someone who's been on it for 18 months?
No, acoramidis doesn't replace tafamidis. Both medications are FDA-approved transthyretin stabilizers for treating ATTR-CM, and they work similarly by preventing the protein from breaking apart and forming amyloid deposits.
Acoramidis is a newer treatment option approved in 2024, while tafamidis has been available since 2019. Studies show both medications can improve heart function and help people live longer, especially when started early.
If you've been on tafamidis for 18 months and it's working well for you, there's no automatic need to switch. The decision to stay on tafamidis or consider acoramidis should be made with your cardiologist based on:
* How well you're responding to your current treatment
* Any side effects you're experiencing
* Your insurance coverage and medication costs
* Your doctor's clinical judgment about what's best for your specific situation
Both medications offer long-term benefits, so continuing what's already working for you may be the right approach.
December 5, 2025